HopeStage
Back to all studies
TerminatedNCT04316559

Biased Opioid Agonists for Treatment of Opioid Withdrawal in OUD

Medication studyAges 18–75United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 75 years.

Listed locations
BaltimoreSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: December 27, 2021
Recruitment status
Terminated
Enrollment listed in the registry
5
Sponsor
National Institute on Drug Abuse (NIDA)
Sponsor type
Research institute
Study type
Drug
Intervention type
Medication / drug, OTHER
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 75 Years
Official registry ID
NCT04316559
Official title
Show the full official title

Biased Opioid Agonists for Treatment of Opioid Withdrawal in OUD: A Dose-Finding Pilot and Within-Subject Randomized Inpatient Trial

Recruitment & locations

Terminated

Baltimore

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is National Institute on Drug Abuse (NIDA), a research institute.

Does this study involve medication?

Yes. The study involves medication, including TRV734 and Oxycodone.

Who can participate?

Listed age limits: 18 years to 75 years.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies